Instil Bio, Inc.
TIL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001789769
No open-market purchases or sales by Instil Bio, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $29.2M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Instil Bio, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- −3 vs. Q1 2025
- Shares held
- 4.65M
- −597.0K (−11.4%) vs. Q1 2025
- Total value
- $96.9M
- +$5.77M (+6.3%) vs. Q1 2025
- New holders
- 9
- 7 more added
- Sold out
- 12
- 13 more reduced
2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TIL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $29.2M |
| Q1 2026 | 32 | $34.6M |
| Q4 2025 | 29 | $48.9M |
| Q3 2025 | 34 | $81.3M |
| Q2 2025 | 38 | $96.9M |
| Q1 2025 | 43 | $91.2M |
| Q4 2024 | 40 | $100.0M |
| Q3 2024 | 49 | $358.0M |
| Q2 2024 | 30 | $43.5M |
| Q1 2024 | 31 | $45.9M |
| Q4 2023 | 30 | $30.0M |
| Q3 2023 | 58 | $34.3M |
| Q2 2023 | 62 | $45.3M |
| Q1 2023 | 73 | $60.9M |
| Q4 2022 | 79 | $64.1M |
| Q3 2022 | 95 | $577.0M |
| Q2 2022 | 99 | $550.9M |
| Q1 2022 | 79 | $1.27B |
| Q4 2021 | 77 | $1.99B |
| Q3 2021 | 64 | $1.28B |
| Q2 2021 | 62 | $1.35B |
| Q1 2021 | 56 | $1.62B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Instil Bio, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 1 | $21 | 0.00% | −1−50.0% | Reduced |
| FMR LLC | 5 | $110 | 0.00% | −74−93.7% | Reduced |
| Frazier Financial Advisors, LLC | 15 | $313 | 0.00% | 00.0% | Unchanged |
| Eq Wealth Advisors, LLC | 40 | $833 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 114 | $2.37K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 215 | $4.48K | 0.00% | −1,177−84.6% | Reduced |
| Royal Bank of Canada | 335 | $7.00K | 0.00% | +335 | New |
| Bokf, NA | 454 | $9.46K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,040 | $21.7K | 0.00% | +1,006+2,958.8% | Added |
| Raymond James Financial Inc | 1,433 | $29.9K | 0.00% | +1,433 | New |
| BNP Paribas Arbitrage, SA | 2,727 | $56.8K | 0.00% | −505−15.6% | Reduced |
| GF Fund Management Co. Ltd. | 3,000 | $62.5K | 0.00% | +3,000 | New |
| Quest Partners LLC | 7,987 | $166.4K | 0.02% | +2,590+48.0% | Added |
| Barclays PLC | 10,400 | $216.6K | 0.00% | −4,426−29.9% | Reduced |
| Americana Partners, LLC | 12,926 | $269.2K | 0.01% | +12,926 | New |
| Exome Asset Management LLC | 16,200 | $337.4K | 0.28% | +16,200 | New |
| UBS Group AG | 16,219 | $337.8K | 0.00% | −1,061−6.1% | Reduced |
| Trexquant Investment LP | 17,369 | $361.8K | 0.00% | +17,369 | New |
| State Street Corp | 17,595 | $366.5K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 43,094 | $898.0K | 0.00% | −121−0.3% | Reduced |
| Macquarie Group Ltd | 50,000 | $1.04M | 0.00% | +50,000 | New |
| BlackRock, Inc. | 50,733 | $1.06M | 0.00% | −7,238−12.5% | Reduced |
| Assenagon Asset Management S.A. | 57,497 | $1.20M | 0.00% | +4,400+8.3% | Added |
| Northern Trust Corp | 64,413 | $1.34M | 0.00% | +64,413 | New |
| Renaissance Technologies LLC | 70,655 | $1.47M | 0.00% | −34,288−32.7% | Reduced |
| Boxer Capital Management, LLC | 70,700 | $1.47M | 0.74% | −9,425−11.8% | Reduced |
| Dimensional Fund Advisors LP | 82,822 | $1.73M | 0.00% | +5,473+7.1% | Added |
| Sectoral Asset Management Inc | 86,220 | $1.80M | 1.19% | +86,220 | New |
| Balyasny Asset Management LLC | 88,796 | $1.85M | 0.00% | −228,528−72.0% | Reduced |
| Morgan Stanley | 96,308 | $2.01M | 0.00% | +76,957+397.7% | Added |
| Millennium Management LLC | 108,097 | $2.25M | 0.00% | −104,147−49.1% | Reduced |
| Goldman Sachs Group Inc | 163,261 | $3.40M | 0.00% | +30,830+23.3% | Added |
| Vanguard Group Inc | 168,098 | $3.50M | 0.00% | 00.0% | Unchanged |
| Siren, L.L.C. | 203,933 | $4.25M | 0.22% | 00.0% | Unchanged |
| Vivo Capital, LLC | 292,743 | $6.10M | 0.62% | −292,742−50.0% | Reduced |
| CPMG Inc | 410,922 | $8.56M | 38.82% | 00.0% | Unchanged |
| BML Capital Management, LLC | 534,899 | $11.1M | 8.54% | +118,179+28.4% | Added |
| Curative Ventures V LLC | 1,899,004 | $39.6M | 100.00% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −116,785−100.0% | Sold out |
| Velan Capital Investment Management LP | 0 | $0 | 0.00% | −69,000−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| VR Adviser, LLC | 0 | $0 | 0.00% | −33,177−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −31,314−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −24,328−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −22,298−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −18,700−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −13,864−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −13,490−100.0% | Sold out |
| Palo Alto Investors LP | 0 | $0 | 0.00% | −11,165−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −10,511−100.0% | Sold out |
| Pinpoint Asset Management Ltd | – | – | – | – | Not filed |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |